LGR4 interacts with RhoA to modulate cell survival and epithelial-mesenchymal transition via the Wnt/β-catenin pathway in benign prostatic hyperplasia.
Oct 2026· Biochimica et Biophysica Acta - Molecular Basis of Disease· pp.
168499
· 0 citations· 75 references
Medicine
TL;DR
It is demonstrated that LGR4 was overexpressed in BPH and localized within the stromal and epithelial components of prostate and regulated the Wnt/β-catenin pathway by interacting with RhoA to control cellular proliferation, apoptosis and EMT, while barely affected cell cycle.
Abstract
Background
Benign prostatic hyperplasia (BPH), a prevalent disorder among elderly men, still has an unclear etiology. Leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4) plays a pivotal role in cellular proliferation, differentiation and epithelial-mesenchymal transition (EMT) in various tissues. This study was designed to investigate the roles of LGR4 in BPH.
Methods
Human prostate tissues, cultured human prostate cell (BPH-1 and WPMY-1) were utilized to detect LGR4 expression and localization by immunofluorescence staining, RT-PCR, and Western Blot. LGR4 deficient and overexpression cell models were established. Using these models, the levels of cellular viability, apoptosis, cell cycle were quantified by cell counting kit-8 assay, flow cytometry, respectively. Apoptosis-related proteins, cycle-associated proteins, EMT biomarkers and Wnt/β-catenin pathway were measured by Western Blot. Furthermore, a software, AlphaFold3, was used to perform molecular docking analysis between LGR4 and RhoA. We further studied the interaction between LGR4 and RhoA through Co-Immunoprecipitation assay.
Results
Our research findings demonstrated that LGR4 was overexpressed in BPH and localized within the stromal and epithelial components of prostate. LGR4 deficiency promoted apoptosis, arrested the cell cycle, inhibited cell growth and EMT. Conversely, overexpression of LGR4 completely reversed the alterations induced by LGR4 deficiency. We further showed that LGR4 regulated the Wnt/β-catenin pathway by interacting with RhoA to control cellular proliferation, apoptosis and EMT, while barely affected cell cycle.
Conclusions
Overall, our original data indicate that the upregulated LGR4 could interact with RhoA to exert an inhibitory impact on cell apoptosis while promote cellular proliferation and EMT via Wnt/β-catenin pathway.
This study identifies TXNRD1 as a crucial regulator of cellular plasticity and metastasis in NSCLC via the TGF-β1 pathway, suggesting that targeting TXNRD1 may reduce metastatic potential and improve patient survival.
Yaw-Dong Lang, Shin-Yuan Gu, Jou-Ho Shih et al.· Cancer Biology & Therapy· 0 citations
By hindering the Wnt/β-catenin pathway, overexpression of FBXO17 promotes ferroptosis and subsequently inhibits the malignant phenotype and stemness properties of PCa cells.
Experimental data indicated that P4HA3 facilitated GC cell proliferation, migration and invasion, and enhanced glycolytic activity and increased the expression of key glycolysis-related proteins, suggesting that P4HA3 may induce a broader metabolic activation rather than an exclusively glycolytic shift.
Tao Wang· Pakistan Journal of Pharmace...· 0 citations
HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways and correlated with poor patient survival; critically, high HIST1H4L expression correlated with poor patient survival.
Shi-Cheng Feng, Min Feng, Zhi-Qiang Lu et al.· Frontiers in Oncology· 0 citations
Objective: Endometrial cancer (EC) is one of the most common cancers in women, and its incidence is increasing worldwide. The prognosis of recurrent and advanced cancer remains poor because treatment options are limited. Ubiquitin C-terminal hydrolase-L1 (UCHL1) is associated with the progression of several cancers inc...
Azusa Kobayashi, Kohshiro Nakao, N. Inoue et al.· Biomedicines· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.